Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Yingke Capital

Founders Mingfei Qian

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 84
Average round size
info
The average size of a deal this fund participated in
$157M
Portfolio companies 76
Rounds per year 6.00
Lead investments 22
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 13
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Manufacturing
  • Medical
  • Pharmaceutical
Summary

In 2006 was created Yingke Capital, which is appeared as VC.

The high activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. This Yingke Capital works on 15 percentage points less the average amount of lead investments comparing to the other organizations. When the investment is from Yingke Capital the average startup value is more than 1 billion dollars.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Yingke Capital, startups are often financed by Zhongtai Chuanghui Equity Investment Fund, Xiaomi, Warmsun Holding Group. The meaningful sponsors for the fund in investment in the same round are Yueyin Venture Capital, Tigermed, TF Capital. In the next rounds fund is usually obtained by Tianjin Haida Venture Capital Management, Shenzhen Capital Group, Share Capital.

The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the various public portfolio startups of the fund, we may underline Royole Corporation, Zelgen, Haihe Biopharma Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Yingke Capital:
Typical Co-investors
Yingke Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Yingke Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
350 Investment Partners England, United Kingdom, Warrington
AJI Capital Huntington, New York, United States
Ayer Capital Management California, San Francisco, United States
Baicizhan Chengdu, China, Sichuan
Cairn Investment Group -
DRW Venture Partners Austin, Texas, United States
Ehong Capital Co., Ltd. -
Enpact Berlin, Berlin, Germany
F&M INVESTMENT OFFICE -
Fenqile China, Guangdong, Shenzhen
Guangkong Kangfu Yongpin China, Hong Kong, Hong Kong Island
Huaan Securities Anhui, China, Hefei
Impact51 Kusnacht, Switzerland, Zurich
M-Industry Connecticut, Stamford, United States
Omicron Capital Missouri, St Louis, United States
Orbis Investment Management Bermuda, Hamilton
Teamworthy Ventures New York, New York, United States
webMethods Fairfax, United States, Virginia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

WestGene Biopharma

Biopharma
Medical
Pharmaceutical
Therapeutics
$46M20 Jun 2023 Chengdu, Sichuan, China

Junde Pharmaceutical

Health Care
Medical
31 May 2023 Xiamen, China

Huizhou Yipeng Energy Technology Co., Ltd.

Electric Vehicle
Energy Efficiency
Manufacturing
$27M05 Dec 2022 Huizhou, Guangdong Province, China

Chengmandian Energy Technology

Battery
Clean Energy
Electric Vehicle
Energy Management
Energy Storage
$15M01 Dec 2022 Chuzhou, Anhui, China

Dreamworld AR

Augmented Reality
Virtual Reality
11 Nov 2022 San Mateo, California, United States

Fourier

Application Specific Integrated Circuit (ASIC)
Audio
Semiconductor
31 Aug 2022 Xuhui, Shanghai, China

Sunwoda Electric Vehicle Battery

Battery
$1B16 Aug 2022 Shanghai, Shanghai, China

Chinagene Tech

Clinical Trials
Enterprise
$15M30 Mar 2022 Changping District, Beijing, China

Gene Vector

Biotechnology
Genetics
$3M10 Mar 2022 Chengdu, Sichuan, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Yingke Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 84
Average round size 157M
Rounds per year 6.00
Peak activity year 2021
Lead investments 22
Follow on index 0.10
Exits 13
Group Appearance index 0.56

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

WestGene Biopharma

Biopharma
Medical
Pharmaceutical
Therapeutics
$46M20 Jun 2023 Chengdu, Sichuan, China

Junde Pharmaceutical

Health Care
Medical
31 May 2023 Xiamen, China

Huizhou Yipeng Energy Technology Co., Ltd.

Electric Vehicle
Energy Efficiency
Manufacturing
$27M05 Dec 2022 Huizhou, Guangdong Province, China

Chengmandian Energy Technology

Battery
Clean Energy
Electric Vehicle
Energy Management
Energy Storage
$15M01 Dec 2022 Chuzhou, Anhui, China

Dreamworld AR

Augmented Reality
Virtual Reality
11 Nov 2022 San Mateo, California, United States

Fourier

Application Specific Integrated Circuit (ASIC)
Audio
Semiconductor
31 Aug 2022 Xuhui, Shanghai, China

Sunwoda Electric Vehicle Battery

Battery
$1B16 Aug 2022 Shanghai, Shanghai, China

Chinagene Tech

Clinical Trials
Enterprise
$15M30 Mar 2022 Changping District, Beijing, China

Gene Vector

Biotechnology
Genetics
$3M10 Mar 2022 Chengdu, Sichuan, China
Crunchbase icon

Content report

The following text will be sent to our editors: